Effects of hydrogen water and psychological treatment in a sample of women with panic disorder: a randomized and controlled clinical trial
Research suggests that inflammation is an important mediator in the pathophysiology of anxiety disorders. In addition, women are more likely to develop an anxiety and depression disorder, in comorbidity with a wide spectrum of diseases related to the immune system. In recent years, hydrogen-rich water has emerged as a promising therapeutic strategy to prevent and intervene in stress-related disorders, due to its antioxidant and anti-inflammatory properties. The present study aims to analyze the effects of psychological treatment and a hydrogen-rich drink on the severity of anxiety and depression, pro-inflammatory cytokine levels, the cortisol awakening response, and general health state in a sample of women with panic disorder. This is a completely randomized, placebo-controlled study. The treatment group simultaneously received psychological treatment and 1.5 L of hydrogenated water for three months, compared to the control group that received psychological treatment and placebo. The results show that the treatment group was not significantly better than the control group. But there was a further reduction in measured pro-inflammatory cytokine scores, improving body pain and physical health. When between-group treatment effects were removed, psychological treatment significantly decreased measured variables, including cytokines and cortisol. The results support the presence of a maladaptive inflammatory process in women with panic disorder.
1. Barlow DH. Anxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic. 2nd ed. The Guilford Press;2002.
2. Audet MC. Stress-induced disturbances along the gut microbiota-immune-brain axis and implications for mental health: does sex matter? Front Neuroendocrinol.2019;54:100772. doi:10.1016/j.yfrn e.2019.100772
3. Jalnapurkar I, Allen M, Pigott AT. Sex Differences in Anxiety Disorders: A Review. Psychiatry, Depression&Anxiety.2018;4:1-9.doi:10.24966/PDA-0150/100011
4. Alessi MG, Bennett JM. Mental health is the health of the whole body: How psychoneuroimmunology&health psychology can inform& improve treatment. J Eval Clin Pract. Published online March 14,2020:jep.13386. doi:10.1111/jep.13386
5. Amini-Khoei H, Haghani-Samani E, Beigi M,et al.On the role of corticosterone in behavioral disorders,microbiota composition alteration and neuroimmune response in adult male mice subjected to maternal separation stress. Int Immunopharmacol.2019;66:242-250.doi:10.1016/j.intimp.2018.11.037
6. Dinan TG, Cryan JF. Brain-gut-microbiota axis and mental health. Psychosom Med.2017;79(8):920-926.d oi:10.1097/PSY.0000000000000519
7. Foster JA, Rinaman L, Cryan JF. Stress& the gut-brain axis: regulation by the microbiome. Neurobiol Stress.2017;7:124-136.doi:10.1016/j.ynstr.2017.03.001
8. Paiva IHR, Duarte-Silva E, Peixoto CA. The role of prebiotics in cognition, anxiety, and depression. Eur Neuropsychopharmacol.2020;34:1-18.doi:10.1016/j.e uroneuro.2020.03.006
9. Sarkar A, Harty S, Lehto SM, et al. The Microbiome in Psychology and Cognitive Neuroscience. Trends Cogn Sci.2018;22(7):611-636.doi:10.1016/j.tics.2018.04.006
10. Kuti D, Winkler Z, Horvath K,et al.
Gastrointestinal(non-systemic) antibiotic rifaximin differentially affects chronic stress-induced changes in colon microbiome and gut permeability without effect on behavior. Brain Behav Immun.
2020;84:218-228.doi:10.1016/j.bbi.2019.12.004
11. Morkl S, Butler MI, Holl A, Cyran JF, Dinan TG.Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry. Curr Nutr Rep. Published online May 13,2020.doi:10.1007/s13668-020-00313-5
12. Burokas A, Arboleya S, Moloney RD, et al.Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biol Psychiatry.2017;82(7):472-487. doi:10.1016/j.biopsyc h.2016.12.031
13. Furtado M, Katzman MA. Neuroinflammatory pathways in anxiety, posttraumatic stress, and obsessive compulsive disorders. Psychiatry Res.2015;229(1-2):37-48.doi:10.1016/j.psychres.2015.05.036
14. Michopoulos V, Powers A, Gillespie CF, Ressler KJ,Jovanovic T. Inflammation in fear-and anxiety-based disorders: PTSD, GAD, and beyond.
Neuropsychopharmacology.2017;42(1):254.
15. Quagliato LA, Nardi AE. Cytokine alterations in panic disorder: a systematic review. J Affect Disord.2018;228:91-96.doi:10.1016/j.jad.2017.11.094
16. Rea K,Dinan TG, Cryan JF. Gut Microbiota: A Perspective for Psychiatrists. Neuropsychobiology.2020;79(1):50-62. doi:10.1159/000504495
17.Salim S, Chugh G, Asghar M. Inflammation in anxiety. In: Advances in Protein Chemistry and Structural Biology. Vol 88. Elsevier;2012:1-25.
18.Tao H, Wang CR, Guo JC, Guo M. Research Progress on the Relationship between Intestinal Flora and Mental and Psychological Diseases. Advances in Microbiology.2020;10(06):295-305.doi:10.4236/aim.2020.106021
19.Gao Q,Song H, Wang X ting,et al. Molecular hydrogen increases resilience to stress in mice. Sci Rep.2017;7(1):9625. doi:10.1038/s41598-017-10362-6
20.Iketani M, Ohsawa I. Molecular Hydrogen as a Neuroprotective Agent. Curr Neuropharmacol.2017;15(2):324-331. doi:10.2174/1570159X14666160607205417
21.Mizuno K, Sasaki A,Ebisu K,et al. Hydrogen-rich water for improvements of mood, anxiety, and autonomic nerve function in daily life. Med Gas Res.2017;7(4):247. doi:10.4103/2045-9912.222448
22.Yang Y,Zhu Y,Xi X.Anti-inflammatory and antitumor action of hydrogen via reactive oxygen species(Review). Oncol Lett. Published online June 26,2018.doi:10.3892/ol.2018.9023
23. Mikami T, Tano K, Lee H, et al. Drinking hydrogen water enhances endurance and relieves psychometric fatigue: a randomized, double-blind, placebo-controlled study. Can J Physiol Pharmacol.2019;97(9):857-862.doi:10.1139/cjpp-2019-0059
24. Spulber S, Edoff K, Hong L, Morisawa S, Shirahata S, Ceccatelli S. Molecular Hydrogen Reduces LPS-Induced Neuroinflammation and Promotes Recovery from Sickness Behaviour in Mice. PLoS One.2012;7(7).doi:10.1371/journal.pone.0042078
25.Guo Q,Yin X,Qiao M,et al.Hydrogen-Rich Water Ameliorates Autistic-Like Behavioral Abnormalities in Valproic Acid-Treated Adolescent Mice Offspring.Front Behav Neurosci.2018;12. doi:10.3389/fnbeh.2018.00170
26. Niu Y, Nie Q, Dong L, et al. Hydrogen Attenuates Allergic Inflammation by Reversing Energy Metabolic Pathway Switch. Sci Rep.2020;10. doi:10.1038/s41598-020-58999-0
27. Sim M, Kim CS, Shon WJ, Lee YK, Choi EY, Shin DM. Hydrogen-rich water reduces inflammatory responses and prevents apoptosis of peripheral blood cells in healthy adults: a randomized, double-blind,controlled trial. Sci Rep.2020;10. doi:10.1038/s41598-020-68930-2
28. Tanaka Y, Kanazawa M, Kano M, et al. Differential activation in amygdala and plasma noradrenaline during colorectal distention by administration of corticotropin-releasing hormone between healthy individuals and patients with irritable bowel syndrome. PLoS ONE.2016;11(7).http://search.ebsco host.com/login.aspx?direct=true&db=psyh&AN=2016-39996-001&lang=es&site=ehost-live
29. Ghanizadeh A, Berk M. Molecular hydrogen: an overview of its neurobiological effects and therapeutic potential for bipolar disorder and schizophrenia. Med Gas Res. 2013;3(1):11. doi:10.1186/2045-9912-3-11
30.Zhang Y,Xu J,Yang H. Hydrogen: An Endogenous Regulator of Liver Homeostasis. Front Pharmacol.2020;11.doi:10.3389/fphar.2020.00877
31.Cordero-Andrés P, González-Blanch C, Umaran-Alfageme O,et al. Tratamiento psicologico de los trastornos emocionales en atencion primaria:fundamentos teoricos y empiricos del estudio PsicAP.Ansiedad YEstrés.2017;23(2-3):91-98.
32. Lelli L, Castellini G, Cassioli E, Monteleone AM,Ricca V. Cortisol levels before and after cognitive behavioural therapy in patients with eating disorders reporting childhood abuse: A follow-up study.Psychiatry Res.2019;275:269-275. doi:10.1016/j.psych res.2019.03.046
33. Lopresti AL. Cognitive behaviour therapy and inflammation: A systematic review of its relationship and the potential implications for the treatment of depression. Aust NZJ Psychiatry. 2017;51(6):565-582.doi:10.1177/0004867417701996
34. Manigault AW, Shorey RC, Hamilton K, et al.Cognitive behavioral therapy, mindfulness, and cortisol habituation: a randomized controlled trial.Psychoneuroendocrinology.2019;104:276-285.doi:10.1016/j.psyneuen.2019.03.009
35. Zabihiyeganeh M, Vafaee Afshar S, Amini Kadijani A, et al. The effect of cognitive behavioral therapy on the circulating proinflammatory cytokines of fibromyalgia patients: a pilot controlled clinical trial.Gen Hosp Psychiatry.2019;57:23-28. doi:10.1016/j.gen hosppsych.2019.01.003
36. Barlow DH, Craske MG. Mastery of Your Anxiety and Panic. Graywind Publications; 1989.
37. World Health Organization. Guia de bolsillo de la classificacion CIE-10: clasificacion de los trastornos mentales y del comportamiento. Editorial Médica Panamericana;2000.https://apps.who.int/iris/handl e/10665/42326
38. Cohen S, Kamarck T, Mermelstein R. A Global Measure of Perceived Stress. J Health Soc Behav.1983;24(4):385. doi:10.2307/2136404
39. Remor E. Psychometric Properties of a European Spanish Version of the Perceived Stress Scale(PSS).Span J Psychol.2006;9(1):86-93. doi:10.1017/S1138741600006004
40. Remor E, Carrobles JA. Versión Espanola de la Escala de Estrés Percibido(PSS-14): Estudio psicométrico en una muestra VIH+.[Spanish version of the Perceived Stress Scale(PSS-14): Psychometric study in a HIV+ sample.]. Ansiedad y Estrés.2001;7(2-3):195-201.
41. Buela-Casal G, Guillen-Riquelme A, Seisdedos N.Cuestionario de Ansiedad Estado-Rasgo. 9th ed. TEA Ediciones;2015.
42. Spielberger CD, Gorsuch RL, Lushene RE. STAI.Manual for the State-Trait Anxiety Inventory(Self-Evaluation Questionnaire). Consulting Psychologist Press;1970.
43. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry.1961;4:561-571.
44. Beck AT, Steer RA, Ball R, Ranieri WF. Comparison of Beck Depression Inventories-IA and-II in Psychiatric Outpatients. J Pers Asses.
1996;67(3):588-597.doi:10.1207/s15327752jpa6703_1
45.Sanz J,García-Vera MP, Espinosa R,Fortún M,Vazquez C. Adaptacion espanola del Inventario para la Depresión de Beck-II(BDI-II):3. Propiedades psicométricas en pacientes con trastornos psicológicos. Clinica y Salud.2005;16:23.
46. Dimenas E,Glise H, Hallerback B, Hernqvist H,Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol. 1995;30(11):1046-1052.
47. Kulich KR, Piqué JM, Vegazo O,et al. Validacion psicométrica de la traduccion al espanol de la escala de evaluación de sintomas gastrointestinales(GSRS) y del cuestionario de calidad de vida de reflujo y dispepsia(QOLRAD) en los pacientes con enfermedad por reflujo gastroesofagico. Revista clinica espanola.2005;205(12):588-594.
48. Revicki DA, Wood M, Wiklund I, Crawley J.Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res.1997;7(1):75-83.
49. Alonso J. La version espanola del SF-36 Health Survey(Cuestionario de Salud SF-36):un instrumento para la medida de los resultados clinicos. Medicina Clinica.1995;104:771-776.
50. Alonso J, Prieto L, Ferrer M, et al. Testing the measurement properties of the Spanish version of the SF-36 Health Survey among male patients with chronic obstructive pulmonary disease. J Clin Epidemiol.1998;51(11):1087-1094.
51.López-Garcia E,Banegas JR,Pérez-Regadera AG,Gutiérrez-Fisac JL, Alonso J, Rodriguez-Artalejo F.Valores de referencia de la version espanola del Cuestionario de Salud SF-36 en poblacion adulta de mas de 60 anos. Medicina Clinica.
2003;120(15):568-573.doi:10.1016/S0025-7753(03)73775-0
52. Maruish ME. User's Manual for the Sf-36v2 Health Survey. 3rd ed. QualityMetric Incorporated;2009.
53. Vilagut G, Maria Valderas J, Ferrer M, Garin O,Lopez-Garcia E, Alonso J. Interpretación de los cuestionarios de salud SF-36 y SF-12 en Espana:componentes fisico y mental. Medicina Clinica.2008;130(19):726-735. doi:10.1157/13121076
54. Ware JE. How to Score the Revised MOS Short-Form Health Scale(SF-36®). The Health Institute, New England Medical Center Hospitals; 1988:10,17-18.
55. Ware JE, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME. User's Manual for the SF-36v2 Health Survey. 2nd ed. QualityMetric Incorporated;2007.
56. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. The Health Institute, New England Medical Center Hospitals; 1993.
57. Cohen A, Colodner R, Masalha R, Haimov I. The Relationship Between Tobacco Smoking, Cortisol Secretion, and Sleep Continuity. Subst Use Misuse.2019;54(10):1705-1714. doi:10.1080/10826084.2019.1608250
58. Powell DJ, Schlotz W. Daily Life Stress and the Cortisol Awakening Response: Testing the Anticipation Hypothesis. PLoS ONE.2012;7(12):e52067. doi:10.1371/journal.pone.0052067
59. Fekedulegn DB, Andrew ME, Burchfiel CM,et al.Area Under the Curve and Other Summary Indicators of Repeated Waking Cortisol Measurements: Psychosom Med.2007;69(7):651-659. doi:10.1097/PS Y.0b013e31814c405c
60. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology.2003;28(7):916-931.doi:10.1016/S0306-4530(02)00108-7
61. Angeloni S, Cordes R, Dunbar S,et al.xMAP® Cookbook. A collection of methods and protocols for developing multiplex assays with xMAP Technology. Luminex xMAP Technology;2013.http://www.lumine xcorp.com
62. Arellano-Garcia ME, Hu S, Wang J,et al.Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva. Oral Dis.2008;14(8):705-712.doi:10.1111/j.1601-0825.2008.01488.x
63. Bjerre M, Hansen TK, Flyvbjerg A, Tonnesen E.Simultaneous detection of porcine cytokines by multiplex analysis: development of magnetic bioplex assay. Vet Immunol Immunopathol.2009;130(1-2):53-58.doi:10.1016/j.vetimm.2009.01.007
64. Craske MG, Lewin MR. Trastorno por panico. In:Manual para el tratamiento cognitivo-conductual de los trastornos psicologicos. Trastornos por ansiedad,sexuales,afectivos y psicoticos. Vol 1. Siglo XXI;2007:777.
65. Moreno P, Martín JC. Tratamiento psicológico del trastorno de panico y la agorafobia: manual para terapeutas. 2nd ed. Desclée de Brouwer;2011.
66. Ouabbou S, He Y, Butler K, Tsuang M.Inflammation in Mental Disorders: Is the Microbiota the Missing Link? Neurosci Bull. Published online June 27,2020. doi:10.1007/s12264-020-00535-1
67. Rizzetto L, Fava F, Tuohy KM, Selmi C. Connecting the immune system, systemic chronic inflammation and the gut microbiome: the role of sex. J Autoimmun.2018;92:12-34.doi:10.1016/j.jaut.2018.05.008
68. Zhong J, Shi G.Editorial: Regulation of Inflammation in Chronic Disease. Front Immunol.2019;10.doi:10.3389/fimmu.2019.00737
69. Cano-Vindel A. Los desordenes emotionales en atencion primaria. Ansiedad y Estrés.2011;17(1):75-97.
70. Haro JM, Palacín C, Vilagut G,et al. Prevalencia de los trastornos mentales y factores asociados:resultados del estudio ESEMeD-Espana. Medicina Clinica.2006;126(12):445-451.
71. Zhang JM, An J.Cytokines, Inflammation and Pain.Int Anesthesiol Clin.2007;45(2):27-37.doi:10.1097/AIA.0b013e318034194e
72. Cryan JF, O'Riordan KJ, Cowan CSM,et al. The Microbiota-Gut-Brain Axis. Physiol Rev.2019;99(4):1877-2013.doi:10.1152/physrev.00018.2018
73. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci.2011;12(8):453.
74. Misiak B, Loniewski I, Marlicz W,et al. The HPA axis dysregulation in severe mental illness: can we shift the blame to gut microbiota? Prog Neuropsychopharmacol BiolPsychiatry.2020;102:109951.doi:10.1016/j.pnpbp.2020.109951
75. Schnorr SL, Bachner HA. Integrative Therapies in Anxiety Treatment with Special Emphasis on the Gut Microbiome. Yale J Biol Med. 2016;89(3):397-422.
76. Cook MD, Allen JM, Pence BD,et al. Exercise and gut immune function: evidence of alterations in colon immune cell homeostasis and microbiome characteristics with exercise training. Immunol Cell Biol.2016;94(2):158-163.doi:10.1038/icb.2015.108
77. Cussotto S, Strain CR,Fouhy F,et al. Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function.Psychopharmacology.2019;236(5):1671-1685.doi:10.1007/s00213-018-5006-5
78. Gao T, Wang Z, Dong Y,et al. Role of melatonin in sleep deprivation-induced intestinal barrier dysfunction in mice. J Pineal Res. Published online April 12,2019:e12574. doi:10.1111/jpi.12574
79. Hillemacher T, Bachmann O, Kahl KG, Frieling H.Alcohol, microbiome, and their effect on psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry.2018;85:105-115.doi:10.1016/j.pnpbp.2018.04.015
80. Leprun PMB, Clarke G. The gut microbiome and pharmacology: a prescription for therapeutic targeting of the gut-brain axis. Curr Opin Pharmacol.2019;49:17-23.doi:10.1016/j.coph.2019.04.007
81. Higashimura Y, Baba Y, Inoue R,et al. Effects of molecular hydrogen-dissolved alkaline electrolyzed water on intestinal environment in mice. Med Gas Res.2018;8(1):6-11.doi:10.4103/2045-9912.229597